2002 Sep 27
The Swedish inventor of modular high-tech facilities - Pharmadule Emtunga AB - announces steps to secure its rapid expansion and patent protecting its technological leadership covering fabrication and sales of Modular Biotechnological Plants.
Stockholm, September 26, 2002 – Pharmadule Emtunga has made a substantial expansion of its production capacity by entering into a strategic production alliance and by establishing a new facility in Partille, Gothenburg region, generating a positive and lasting impact on Pharmadule Emtungas’s capacity to meet the increasing production and volume demand from the market today and into the future.
Pharmadule Emtunga is the No 1 modular supplier in the world to the pharmaceutical and biotech industry. The company has a long and extensive history since the early seventies with long and extensive experience in the development of modular fabrication for the pharmaceutical and biotech industry. This innovative concept has enabled the supply of large complex facilities, larger than 10,000 sqm and up to 12 month faster when compared with conventional construction.
Division Pharmadule now further strengthens its technical leadership as the world-leading supplier of modular facilities by announcing the acquisition of EU, US and Canadian patents, EP 0 670889, US 5656 491 and Cda 2137 671. The patents relates to construction and sales of Mobile Modular Biotechnological plants. Pharmadule is rapidly growing and investing heavily in development of the modular concept for the Biotech industry. The acquisition of the patents is a logical step to assure that Pharmadule can keep developing technological skills for the benefit of our customers and partners.
För mer information kontakta:
Tomas Wängberg, VD
Tel: + 46-512 32444
Mobil:+46-705 942 444
E-mail: tomas.wangberg@pharmadule.com